XML 78 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jun. 08, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized $ 4,817 $ 4,394 $ 6,380  
Unrecognized Compensation Cost $ 3,060      
Expiration date of 2007 Stock Incentive Plan May 20, 2024      
Outstanding:        
Beginning Balance (in shares)   77,000    
Beginning Balance, weighted average exercise price (in dollars per share)   $ 16.29    
Granted (in shares) 0 0 0  
Granted, weighted average exercise price (in dollars per share) $ 0 $ 0 $ 0  
Stock options exercised (in shares)   77,334 27,619  
Exercised, weighted average exercise price (in dollars per share)     $ 0  
Ending Balance (in shares)     77,000  
Ending balance, weighted average exercise price (in dollars per share)     $ 16.29  
Exercisable (in shares)        
Stock price per share (in dollars per share)       $ 24.70
Intrinsic value under share based compensation scheme   $ 20 $ 85  
Restricted Stock Units (RSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized $ 4,603 $ 4,231 $ 6,263  
Unrecognized Compensation Cost $ 3,060      
Weighted Average Remaining Amortization Periods (in years) 9 months 18 days      
Exercisable (in shares)        
Expected to vest 904,000 986,000 1,004,000  
Outstanding:        
Balance (in shares) 986,000 1,004,000 1,028,000  
Granted (in shares) 252,000 304,000 353,000  
Vested (in shares) (334,000) (322,000) (155,000)  
Cancelled or forfeited (in shares) 0 0 (222,000)  
Balance (in shares) 904,000 986,000 1,004,000  
Beginning balance, Weighted average grant-date fair value (in dollars per share) $ 13.34 $ 12.74 $ 13.24  
Granted, Weighted average grant-date fair value (in dollars per share) 18.90 15.52 11.35  
Vested, Weighted average grant-date fair value (in dollars per share) 13.67 13.54 12.27  
Forfeitures, Weighted average grant date fair value 0 0 13.19  
Ending balance, Weighted average grant-date fair value (in dollars per share) $ 14.77 $ 13.34 $ 12.74  
Phantom Stock Units [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized $ 214 $ 163 $ 117  
Unrecognized Compensation Cost $ 0      
Weighted Average Remaining Amortization Periods (in years) 0 years      
Outstanding:        
Balance (in shares) 157,000 145,000 132,000  
Granted (in shares) 10,000 10,000 10,000  
Dividend equivalents issued 3,000 2,000 3,000  
Redeemed for common stock (in shares) 0 0 0  
Balance (in shares) 170,000 157,000 145,000  
Granted, Weighted average grant-date fair value (in dollars per share) $ 21.35 $ 16.25 $ 11.71  
Performance Vested Restricted Stock Units [Member] | Scheduled to Vest January 1, 2019 [Member]        
Exercisable (in shares)        
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Not Expected To Vest Outstanding Number 0      
Expected to vest 213,000      
Outstanding:        
Balance (in shares) 213,000      
Performance Vested Restricted Stock Units [Member] | Scheduled to Vest January 1, 2020 [Member]        
Exercisable (in shares)        
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Not Expected To Vest Outstanding Number 0      
Expected to vest 167,000      
Outstanding:        
Balance (in shares) 167,000      
Performance Vested Restricted Stock Units [Member] | Scheduled to Vest January 1, 2021 [Member]        
Exercisable (in shares)        
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Not Expected To Vest Outstanding Number 0      
Expected to vest 141,000      
Outstanding:        
Balance (in shares) 141,000      
2007 Stock Incentive Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Maximum number of shares authorized under restricted stock, unrestricted stock, RSU's and stock options to officers, employees and non-employee directors (in shares) 6,500,000      
Exercisable (in shares)        
Available for future grants (in shares) 2,894,000